Article Text

other Versions

PDF
Do mutations of the Pendred syndrome gene, SLC26A4, confer resistance to asthma and hypertension?
  1. Anne C Madeo (madeoa{at}nhgri.nih.gov)
  1. National Institutes of Health, United States
    1. Ani Manichaikul
    1. University of Virginia, United States
      1. Shannon Pryor
      1. NIDCD/ National Institutes of Health, United States
        1. Andrew Griffith (griffita{at}nidcd.nih.gov)
        1. National Institutes of Health, United States

          Abstract

          Mutations of SLC26A4 cause Pendred syndrome, an autosomal recessive disorder comprising goiter and deafness. Based upon recent work in animals, we hypothesize that asthma and hypertension are less prevalent among humans with SLC26A4 mutations. We tested this hypothesis in 210 subjects. The results are consistent with our hypothesis but do not reach significance due to inadequate study size and statistical power. Our hypothesis might represent an example of balancing natural selection with implications for therapeutic strategies to manipulate SLC26A4 expression or function.

          Statistics from Altmetric.com

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.